THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER)
THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve
Sponsor: Edwards Lifesciences
Listed as NCT00530894, this NA trial focuses on Critical Aortic Stenosis and remains completed. Sponsored by Edwards Lifesciences, it has been updated 9 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
May 2017 — Jul 2017 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .